Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « however »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
household < however < hpa  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 90.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (2009) Susan P. Bruce [États-Unis]Recent Developments in the Treatment of Rheumatoid Arthritis
000010 (2011) Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000014 (2012) Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000016 (2009) Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000017 (2011) Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000024 (2012) A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000030 (2010) Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000035 (2013) T. Witte [Allemagne]Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000039 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000050 (2011) Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru HaradaCase of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000057 (2007) Peter Taylor [Royaume-Uni]IL‐6 inhibition in the treatment of rheumatoid arthritis
000074 (2010) Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000085 (2011) Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000087 (2011) K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000096 (2009) Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000098 (2012) H.-I. Huppertz [Allemagne]Biologika bei Kindern und Jugendlichen zur Behandlung rheumatischer Erkrankungen
000102 (2011) Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000161 (2013) I. Kötter [Allemagne] ; J. C. Henes [Allemagne]Etablierte Medikamente
000175 (2012) P. Lehmann [Allemagne] ; E. Huber [Allemagne] ; T. Dörner [Allemagne] ; M. Fleck [Allemagne]Makrophagenaktivierungssyndrom
000181 (2015) Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]Challenges and considerations for development of therapeutic proteins in pediatric patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "however" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "however" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    however
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021